Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Pf-05221304
2. 1370448-25-1
3. Chembl4567446
4. Pf05221304
5. Clesacostat [usan]
6. Clesacostat [inn]
7. 752df9pppi
8. Schembl899298
9. Pf-05221304(clesacostat)
10. Ex-a5142
11. Bdbm50511112
12. S6145
13. Zinc114805174
14. Ac-36590
15. 4-(6-methoxy-4-(7-oxo-1-(propan-2-yl)-1,4,6,7-tetrahydrospiro(indazole-5,4'- Piperidine)-1'-carbonyl)pyridin-2-yl)benzoic Acid
16. Benzoic Acid, 4-(6-methoxy-4-((1,4,6,7-tetrahydro-1-(1-methylethyl)-7-oxospiro(5h-indazole-5,4'-piperidin)-1'-yl)carbonyl)-2-pyridinyl)-
Molecular Weight | 502.6 g/mol |
---|---|
Molecular Formula | C28H30N4O5 |
XLogP3 | 3.2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 5 |
Exact Mass | 502.22162007 g/mol |
Monoisotopic Mass | 502.22162007 g/mol |
Topological Polar Surface Area | 115 Ų |
Heavy Atom Count | 37 |
Formal Charge | 0 |
Complexity | 865 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
84
PharmaCompass offers a list of Clesacostat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Clesacostat manufacturer or Clesacostat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clesacostat manufacturer or Clesacostat supplier.
PharmaCompass also assists you with knowing the Clesacostat API Price utilized in the formulation of products. Clesacostat API Price is not always fixed or binding as the Clesacostat Price is obtained through a variety of data sources. The Clesacostat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Clesacostat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clesacostat, including repackagers and relabelers. The FDA regulates Clesacostat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clesacostat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Clesacostat supplier is an individual or a company that provides Clesacostat active pharmaceutical ingredient (API) or Clesacostat finished formulations upon request. The Clesacostat suppliers may include Clesacostat API manufacturers, exporters, distributors and traders.
Clesacostat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Clesacostat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Clesacostat GMP manufacturer or Clesacostat GMP API supplier for your needs.
A Clesacostat CoA (Certificate of Analysis) is a formal document that attests to Clesacostat's compliance with Clesacostat specifications and serves as a tool for batch-level quality control.
Clesacostat CoA mostly includes findings from lab analyses of a specific batch. For each Clesacostat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Clesacostat may be tested according to a variety of international standards, such as European Pharmacopoeia (Clesacostat EP), Clesacostat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Clesacostat USP).